Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-COV-2 Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04542408
What this trial is testing

Hamburg Edoxaban for Anticoagulation in COVID-19 Study

Who this might be right for
Covid19
Universitätsklinikum Hamburg-Eppendorf 140
Post-approval studies (Phase 4)Ended earlyNCT04656691
What this trial is testing

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

Who this might be right for
Covid19
Daniel Griffin 139
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Not applicableUnknownNCT05227560
What this trial is testing

The Effect of the Emotional Freedom Technique on Students

Who this might be right for
Coping SkillsAnxietyComplementary Therapies+1 more
Zonguldak Bulent Ecevit University 80
Not applicableStudy completedNCT04905823
What this trial is testing

Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

Who this might be right for
Type 1 Diabetes
Paolo Fiorina, MD 600
Not applicableStudy completedNCT04388579
What this trial is testing

Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19

Who this might be right for
Respiratory Disease
University of Lisbon 100
Testing effectiveness (Phase 2)Study completedNCT05205096
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Not applicableUnknownNCT05124535
What this trial is testing

Population-based Age-stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection in the Federation of Bosnia and Herzegovina

Who this might be right for
SeroprevalenceAntibodyCOVID-19
Institute for Public Health of the Federation of Bosnia and Herzegovina 1,152
Not applicableStudy completedNCT04810117
What this trial is testing

Monitoring the IgG/IgM Antibodies in COVID-19 Patients

Who this might be right for
COVID-19 Infections
University of Sargodha 373
Not applicableStudy completedNCT04770740
What this trial is testing

Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19

Who this might be right for
Covid19
Canisius-Wilhelmina Hospital 40
Large-scale testing (Phase 3)Study completedNCT04822818
What this trial is testing

EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19

Who this might be right for
Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)Virus Diseases+5 more
Assistance Publique - Hôpitaux de Paris 96
Not applicableStudy completedNCT05621915
What this trial is testing

Nadroparin Pharmacokinetics in Different Stages of COVID-19

Who this might be right for
ThrombosisNadroparinCOVID-19+2 more
Medical University of Lublin 43
Not applicableStudy completedNCT05054218
What this trial is testing

COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

Who this might be right for
Covid19SARS-CoV2 Infection
H. Lee Moffitt Cancer Center and Research Institute 336
Testing effectiveness (Phase 2)Ended earlyNCT05122182
What this trial is testing

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
University of Sydney 49
Not applicableEnded earlyNCT05142540
What this trial is testing

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines

Who this might be right for
Anti-SARS-CoV-2 Antibody Response
Medical University of Graz 140
Early research (Phase 1)WithdrawnNCT04371640
What this trial is testing

Sirolimus in COVID-19 Phase 1

Who this might be right for
SARS-CoV-2Covid-19
Walter K. Kraft
Testing effectiveness (Phase 2)Study completedNCT04312997
What this trial is testing

The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection

Who this might be right for
COVID-19
Pulmotect, Inc. 101
Not applicableStudy completedNCT02788903
What this trial is testing

A Patient-Centered PaTH to Addressing Diabetes

Who this might be right for
ObesityDiabetesCovid19
Milton S. Hershey Medical Center 2,622,164
Not applicableStudy completedNCT04906850
What this trial is testing

Evaluation of the New Variant 501Y.V2 of COVID-19

Who this might be right for
Covid19
Centre Hospitalier Régional Metz-Thionville 250
Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Next Page